Long-term vaccine-induced heterologous protection against H5N1 influenza viruses in the ferret model

被引:7
作者
Ducatez, Mariette F. [1 ,2 ]
Webb, Ashley [1 ]
Crumpton, Jeri-Carol [1 ]
Webby, Richard J. [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA
[2] Univ Toulouse, ENVT, INP, UMR 1225,INRA, Toulouse, France
关键词
Ferret; H5N1; influenza virus; pandemic; vaccine; PANDEMIC INFLUENZA; A H5N1; IMMUNE-RESPONSES; AVIAN INFLUENZA; HEALTHY-ADULTS; INFECTION; CELLS; HEMAGGLUTININ; IMMUNIZATION; INDIVIDUALS;
D O I
10.1111/j.1750-2659.2012.00423.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Please cite this paper as: Ducatez etal. (2012) Long-term vaccine-induced heterologous protection against H5N1 influenza viruses in the ferret model. Influenza and Other Respiratory Viruses 7(4), 506-512. Background Highly pathogenic H5N1 influenza viruses reemerged in humans in 2003 and have caused fatal human infections in Asia and Africa as well as ongoing outbreaks in poultry. These viruses have evolved substantially and are now so antigenically varied that a single vaccine antigen may not protect against all circulating strains. Nevertheless, studies have shown that substantial cross-reactivity can be achieved with H5N1 vaccines. These studies have not, however, addressed the issue of duration of such cross-reactive protection. Objectives To directly address this using the ferret model, we used two recommended World Health Organization H5N1 vaccine seed strains - A/Vietnam/1203/04 (clade 1) and A/duck/Hunan/795/02 (clade 2.1) - seven single, double, or triple mutant viruses based on A/Vietnam/1203/04, and the ancestral viruses A and D, selected from sequences at nodes of the hemagglutinin and neuraminidase gene phylogenies to represent antigenically diverse progeny H5N1 subclades as vaccine antigens. Results All inactivated whole-virus vaccines provided full protection against morbidity and mortality in ferrets challenged with the highly pathogenic H5N1 strain A/Vietnam/1203/04 5months and 1year after immunization. Conclusion If an H5N1 pandemic was to arise, and with the hypothesis that one can extrapolate the results from three doses of a whole-virion vaccine in ferrets to the available split vaccines for use in humans, the population could be efficiently immunized with currently available H5N1 vaccines, while the homologous vaccine is under production.
引用
收藏
页码:506 / 512
页数:7
相关论文
共 33 条
  • [1] Lessons from pandemic influenza A(H1N1): The research-based vaccine industry's perspective
    Abelin, Atika
    Colegate, Tony
    Gardner, Stephen
    Hehme, Norbert
    Palache, Abraham
    [J]. VACCINE, 2011, 29 (06) : 1135 - 1138
  • [2] Longevity of the protective immune response induced after vaccination with one or two doses of AS03A-adjuvanted split H5N1 vaccine in ferrets
    Baras, Benoit
    Stittelaar, Koert J.
    Kuiken, Thijs
    Jacob, Valerie
    Bernhard, Roger
    Giannini, Sandra
    de Waal, Leon
    van Amerongen, Geert
    Simon, James H.
    Osterhaus, Albert D. M. E.
    Hanon, Emmanuel
    Mossman, Sally P.
    [J]. VACCINE, 2011, 29 (11) : 2092 - 2099
  • [3] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [4] Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans
    Crowe, Brian A.
    Bruehl, Peter
    Gerencer, Marijan
    Schwendinger, Michael G.
    Pilz, Andreas
    Kistner, Otfried
    Koelling-Schlebusch, Katrin
    Aichinger, Gerald
    Singer, Julia
    Zeitlinger, Markus
    Mueller, Markus
    Ehrlich, Hartmut
    Barrett, P. Noel
    [J]. VACCINE, 2010, 29 (02) : 166 - 173
  • [5] Influenza vaccine immunology
    Dormitzer, Philip R.
    Galli, Grazia
    Castellino, Flora
    Golding, Hana
    Khurana, Surender
    Del Giudice, Giuseppe
    Rappuoli, Rino
    [J]. IMMUNOLOGICAL REVIEWS, 2011, 239 : 167 - 177
  • [6] Feasibility of reconstructed ancestral H5N1 influenza viruses for cross-clade protective vaccine development
    Ducatez, Mariette F.
    Bahl, Justin
    Griffin, Yolanda
    Stigger-Rosser, Evelyn
    Franks, John
    Barman, Subrata
    Vijaykrishna, Dhanasekaran
    Webb, Ashley
    Guan, Yi
    Webster, Robert G.
    Smith, Gavin J. D.
    Webby, Richard J.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (01) : 349 - 354
  • [7] Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant
    Goji, Nega Ali
    Nolan, Carrie
    Hill, Heather
    Wolff, Mark
    Noah, Diana L.
    Williams, Tracy B.
    Rowe, Thomas
    Treanor, John J.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (05) : 635 - 641
  • [8] Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge
    Govorkova, Elena A.
    Webby, Richard J.
    Humberd, Jennifer
    Seiler, Jon P.
    Webster, Robert G.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (02) : 159 - 167
  • [9] Heterosubtypic T-cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza
    Goy, Kylie
    Von Bibra, Sally
    Lewis, Jenny
    Laurie, Karen
    Barr, Ian
    Anderson, David
    Hellard, Margaret
    Ffrench, Rosemary
    [J]. INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2008, 2 (04) : 115 - 125
  • [10] Cross-neutralisation of antibodies elicited by an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains
    Hoschler, Katja
    Gopal, Robin
    Andrews, Nick
    Saville, Melanie
    Pepin, Stephanie
    Wood, John
    Zambon, Maria C.
    [J]. INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2007, 1 (5-6) : 199 - 206